Anebulo Pharmaceuticals, Inc. (ANEB) SEC filings
ANEB SEC filings moved a median of 0.00% by the close. ANEB SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ANEB overview →
52 measured ANEB SEC filing events.
Where these ANEB SEC filings landedvs 52 measured ANEB SEC filing reactions
| Middle 50% of ANEB SEC filing reactions | -3.84% to +2.46% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 52 |
Point-in-time · zero look-ahead
Half of the 52 ANEB SEC filing events with a measured close landed between -3.84% and +2.46%; 42% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G Anebulo Pharmaceuticals, | SEC filing · Form 15-12G | -1.44% | -17.70% | |
| Form 25 Anebulo Pharmaceuticals, | SEC filing · Form 25 | -2.18% | +1.39% | |
| Form 10-Q Anebulo Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-Q | — | +3.01% | |
| Form 8-K Anebulo Pharmaceuticals, For: Feb 12 | SEC filing · Form 8-K | — | +3.01% | |
| Form 8-K Anebulo Pharmaceuticals, For: Feb 05 | SEC filing · Form 8-K | +18.18% | +13.72% | |
| Form 8-K Anebulo Pharmaceuticals, For: Jan 29 | SEC filing · Form 8-K | -1.11% | +2.35% | |
| Form 8-K Anebulo Pharmaceuticals, For: Jan 26 | SEC filing · Form 8-K | -4.04% | -8.07% | |
| Form 8-K Anebulo Pharmaceuticals, For: Dec 22 | SEC filing · Form 8-K | -2.66% | -8.51% | |
| Form PRER14A Anebulo Pharmaceuticals, | SEC filing · Form PRER14A | +0.00% | -2.52% | |
| Form 10-K Anebulo Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-K | -1.64% | +2.46% | |
| Form 8-K Anebulo Pharmaceuticals, For: Sep 29 | SEC filing · Form 8-K | -1.64% | +2.46% | |
| Form S-8 POS Anebulo Pharmaceuticals, | SEC filing · Form S-8 | +0.00% | -1.24% | |
| Form EFFECT Anebulo Pharmaceuticals, | SEC filing · Form EFFECT | -1.63% | -0.41% | |
| Form POS AM Anebulo Pharmaceuticals, | SEC filing · Form POS | -0.98% | -3.13% | |
| Form PRER14A Anebulo Pharmaceuticals, | SEC filing · Form PRER14A | +1.01% | -0.41% | |
| Form 8-K Anebulo Pharmaceuticals, For: Sep 12 | SEC filing · Form 8-K | -1.06% | +0.42% | |
| Form 8-K Anebulo Pharmaceuticals, For: Jul 23 | SEC filing · Form 8-K | -2.77% | +2.46% | |
| Form PRE 14A Anebulo Pharmaceuticals, For: Jul 23 | SEC filing · Form PRE | -2.77% | +2.46% | |
| Form S-8 Anebulo Pharmaceuticals, | SEC filing · Form S-8 | — | +0.99% | |
| Form 10-Q Anebulo Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | — | -2.00% | |
| Form 8-K Anebulo Pharmaceuticals, For: May 13 | SEC filing · Form 8-K | — | -2.00% | |
| Form 8-K Anebulo Pharmaceuticals, For: Apr 11 | SEC filing · Form 8-K | — | +9.04% | |
| Form 8-K Anebulo Pharmaceuticals, For: Apr 11 | SEC filing · Form 8-K | — | -3.06% | |
| Form 8-K Anebulo Pharmaceuticals, For: Apr 04 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form ARS Anebulo Pharmaceuticals, For: Jun 30 | SEC filing · Form ARS | — | -2.86% | |
| Form DEF 14A Anebulo Pharmaceuticals, For: Mar 06 | SEC filing · Form DEF | — | -2.86% | |
| Form EFFECT Anebulo Pharmaceuticals, | SEC filing · Form EFFECT | +0.00% | -4.31% | |
| Form 8-K Anebulo Pharmaceuticals, For: Feb 20 | SEC filing · Form 8-K | — | +0.82% | |
| Form PRE 14A Anebulo Pharmaceuticals, For: Feb 24 | SEC filing · Form PRE | — | +0.82% | |
| Form S-3 Anebulo Pharmaceuticals, | SEC filing · Form S-3 | — | -10.64% | |
| Form 10-Q Anebulo Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| Form 8-K Anebulo Pharmaceuticals, For: Feb 14 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K Anebulo Pharmaceuticals, For: Feb 11 | SEC filing · Form 8-K | +0.00% | +2.13% | |
| Form D Anebulo Pharmaceuticals, | SEC filing · Form D | +0.00% | -2.89% | |
| Form 8-K Anebulo Pharmaceuticals, For: Dec 22 | SEC filing · Form 8-K | +1.82% | +47.27% | |
| Form 10-Q Anebulo Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | — | -9.52% | |
| Form 8-K Anebulo Pharmaceuticals, For: Nov 13 | SEC filing · Form 8-K | — | -9.52% | |
| Form 8-K Anebulo Pharmaceuticals, For: Oct 17 | SEC filing · Form 8-K | -2.10% | -3.68% | |
| Form 10-K Anebulo Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-K | +0.00% | +5.95% | |
| Form 8-K Anebulo Pharmaceuticals, For: Sep 25 | SEC filing · Form 8-K | +0.00% | +5.95% | |
| Form 8-K Anebulo Pharmaceuticals, For: Jul 22 | SEC filing · Form 8-K | — | +9.09% | |
| Form 8-K Anebulo Pharmaceuticals, For: Jun 13 | SEC filing · Form 8-K | — | +1.44% | |
| Form 10-Q Anebulo Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | — | -6.36% | |
| Form 8-K Anebulo Pharmaceuticals, For: May 15 | SEC filing · Form 8-K | — | -6.36% | |
| Form 10-Q Anebulo Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-Q | — | +5.43% | |
| Form 8-K Anebulo Pharmaceuticals, For: Feb 13 | SEC filing · Form 8-K | — | +5.43% | |
| Form 8-K Anebulo Pharmaceuticals, For: Nov 20 | SEC filing · Form 8-K | +0.00% | -12.81% | |
| Form 10-Q Anebulo Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -1.79% | +0.00% | |
| Form 8-K Anebulo Pharmaceuticals, For: Nov 14 | SEC filing · Form 8-K | -1.79% | +0.00% | |
| Form ARS Anebulo Pharmaceuticals, For: Jun 30 | SEC filing · Form ARS | — | -10.86% | |
| Form DEF 14A Anebulo Pharmaceuticals, For: Oct 30 | SEC filing · Form DEF | — | -10.86% | |
| Form PRE 14A Anebulo Pharmaceuticals, For: Oct 19 | SEC filing · Form PRE | +0.69% | -8.22% |
Keep exploring
More ANEB: earnings → · analyst actions → · ANEB overview →